Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,814 | 161 | 60.2% |
| Consulting Fee | $1,499 | 2 | 23.6% |
| Travel and Lodging | $937.34 | 3 | 14.8% |
| Education | $89.99 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $2,516 | 12 | $0 (2017) |
| ABBVIE INC. | $1,302 | 66 | $0 (2022) |
| CapsoPro Services LLC | $500.00 | 1 | $0 (2020) |
| Celgene Corporation | $381.21 | 21 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $227.87 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $178.26 | 7 | $0 (2022) |
| STERIS CORPORATION | $168.27 | 1 | $0 (2024) |
| Olympus America Inc. | $129.98 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $111.18 | 6 | $0 (2022) |
| Cook Medical LLC | $105.74 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $383.32 | 11 | STERIS CORPORATION ($168.27) |
| 2023 | $266.55 | 12 | Celgene Corporation ($148.10) |
| 2022 | $748.59 | 38 | ABBVIE INC. ($360.90) |
| 2021 | $780.32 | 36 | AbbVie Inc. ($321.57) |
| 2020 | $773.36 | 21 | CapsoPro Services LLC ($500.00) |
| 2019 | $242.67 | 8 | AbbVie, Inc. ($143.03) |
| 2018 | $252.56 | 16 | AbbVie, Inc. ($170.00) |
| 2017 | $2,893 | 25 | Covidien LP ($2,516) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: GI | ||||||
| 10/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Immunology | ||||||
| 05/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/23/2024 | STERIS CORPORATION | truFreeze (Device) | Food and Beverage | In-kind items and services | $168.27 | General |
| Category: Gastroenterology | ||||||
| 03/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Gastroenterology | ||||||
| 01/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/17/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.60 | General |
| Category: Neuroscience | ||||||
| 09/01/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.11 | General |
| 05/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| Category: Neuroscience | ||||||
| 05/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Neuroscience | ||||||
| 05/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Immunology | ||||||
| 04/13/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.29 | General |
| Category: Neuroscience | ||||||
| 04/12/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Neuroscience | ||||||
| 04/07/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Immunology | ||||||
| 03/14/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| 02/28/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: Neuroscience | ||||||
| 01/30/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Neuroscience | ||||||
| 01/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.72 | General |
| Category: Neuroscience | ||||||
| 12/08/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.58 | General |
| Category: Neuroscience | ||||||
| 10/26/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.92 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,292 | 1,407 | $622,600 | $156,059 |
| 2022 | 30 | 1,546 | 1,823 | $745,185 | $174,858 |
| 2021 | 21 | 1,447 | 1,583 | $605,915 | $148,990 |
| 2020 | 23 | 1,399 | 1,562 | $615,960 | $139,211 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 294 | 358 | $107,400 | $33,734 | 31.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 136 | 141 | $98,700 | $21,470 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 152 | 152 | $53,200 | $19,165 | 36.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 134 | 144 | $86,400 | $10,824 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 150 | $37,500 | $10,331 | 27.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 55 | 72 | $50,400 | $8,560 | 17.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 13 | 14 | $21,000 | $8,202 | 39.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 39 | 39 | $23,400 | $7,238 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 89 | 89 | $22,250 | $6,725 | 30.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 29 | 30 | $27,000 | $6,376 | 23.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 19 | 19 | $15,200 | $3,534 | 23.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $14,700 | $2,860 | 19.5% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $9,800 | $2,744 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 26 | $5,850 | $2,737 | 46.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,625 | $2,672 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 19 | $7,600 | $2,509 | 33.0% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 29 | 30 | $7,500 | $2,227 | 29.7% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $13,300 | $2,069 | 15.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $12,075 | $1,925 | 15.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 37 | 37 | $3,700 | $157.64 | 4.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 299 | 397 | $119,150 | $35,923 | 30.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 128 | 129 | $90,300 | $18,153 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 262 | $65,500 | $16,696 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $32,200 | $10,997 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 136 | 136 | $34,000 | $9,741 | 28.7% |
About Dr. Sam Nourani, M.D
Dr. Sam Nourani, M.D is a Geriatric Medicine healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528039732.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Nourani, M.D has received a total of $6,340 in payments from pharmaceutical and medical device companies, with $383.32 received in 2024. These payments were reported across 167 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,814).
As a Medicare-enrolled provider, Nourani has provided services to 5,684 Medicare beneficiaries, totaling 6,375 services with total Medicare billing of $619,119. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Gastroenterology
- Location Reno, NV
- Active Since 01/27/2006
- Last Updated 10/20/2011
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1528039732
Products in Payments
- Beacon (Device) $1,470
- Barrx (Device) $1,046
- ZEPOSIA (Drug) $383.91
- Humira (Biological) $369.64
- LINZESS (Drug) $270.87
- CREON (Drug) $220.12
- XIFAXAN (Drug) $216.38
- HUMIRA (Biological) $210.69
- STELARA (Biological) $178.26
- truFreeze (Device) $168.27
- RINVOQ (Biological) $124.38
- Olympus EMR & ESD Devices (Device) $106.39
- EchoTip (Device) $105.74
- XELJANZ (Drug) $98.84
- DUPIXENT (Biological) $78.53
- GATTEX (Drug) $64.82
- ZENPEP (Drug) $49.64
- SUCRAID (Drug) $44.16
- ENTYVIO (Biological) $43.38
- VIBERZI (Drug) $41.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Reno
Calvin Vanreken, Md, MD
Geriatric Medicine — Payments: $3,909
Amani Altamimi, M.d, M.D
Geriatric Medicine — Payments: $1,865
Brian Nguyen, Do, DO
Geriatric Medicine — Payments: $799.35
Laurence Gay, Md, MD
Geriatric Medicine — Payments: $455.06
Dr. Dominique Joseph, Md, MD
Geriatric Medicine — Payments: $377.23
Katherine Thyssen, Do, DO
Geriatric Medicine — Payments: $173.71